Global Adipose-derived Stem Cell Market research report by Emergen Research offers strategic insights into the Adipose-derived Stem Cell business sphere and in-depth analysis of the industrial chain analysis, value chain analysis, upstream raw materials, investment strategies, regional expansions, and competitive landscape. For stakeholders, field marketing executives and product owners planning to maintain a competitive edge the market assessment report brings to light essential impression about the growth rate, share and size of the industry during the estimated period. Deep dive into an array of elements including but not limited to the value proposition, product positioning, and targeting and industry segmentation have been described through resources such as charts, tables, and info graphics.
Get a sample of the report : https://www.emergenresearch.com/request-sample/203
Adipose-derived stem cells (ASCs) are mesenchymal stem cells that are present abundantly in adipose tissues and can be differentiated into different cell lineages. Owing to its ability of self-renewal and ability to differentiate into different cell lineages has increased their application in clinical trials of regenerative medicine. ASCs can be harvested in large number from adipose tissues by a minimally invasive procedure, thereby increasing their potential for regenerating tissues and organs damaged by severe injury or chronic diseases.
Key companies in the market include Allocure, Inc., Celgene Corporation, Pluristem Therapeutics, Inc., Intrexon, Inc., Celleris SA, Tissue Genesis, Inc., Mesoblast, Ltd., Antaria, Inc. Thermo Fisher Scientific, Inc., American CryoStem, and Merck KGaA.
Adipose-derived Stem Cell Market research report depicts the latest market scenario with updated trends and segmentation of the products and services. The study provides crucial information on the market situation, size, share, growth factors of the Adipose-derived Stem Cell
Increasing investment in stem cell research, implementation of favorable regulatory policies, and increasing research and development activities are some key factors driving market growth. However, rising number of ethical issues surrounding usage of stem cells in clinical trials, technical limitations associated with delivery and storage of stem cells and high costs of the procedures are some key factors expected to hamper market revenue growth to a certain extent over the forecast period.
For the purpose of this report, Emergen Research has segmented the global adipose-derived stem cell market on the basis of cell type, product type, disease indication, end-use industries, application, and region:
Cell Type Outlook (Revenue, USD Billion; 2018–2028)
- Allogenic
- Autologous
Product Type Outlook (Revenue, USD Billion; 2018–2028)
- Cell Line
- Culture Media
- Media
- Sera
- Reagents
Disease Indication Outlook (Revenue, USD Billion; 2018–2028)
- Cancer
- Obesity
- Wounds Injuries
- Cardiovascular Diseases
- Musculoskeletal
End-use Industries Outlook (Revenue, USD Billion; 2018–2028)
- Cell Banks Tissue Banks
- Research Laboratories Academic Institutes
- Hospitals Trauma Centers
- Others
Application Outlook (Revenue, USD Billion; 2018–2028)
- Therapeutic
- Research
- Others
Regional Outlook (Revenue, USD Billion; 2018–2028)
- North America
- S.
- Canada
- Mexico
- Europe
- Germany
- K.
- France
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East Africa
- Saudi Arabia
- A.E.
- South Africa
- Israel
- Rest of MEA
Request customization of the report: https://www.emergenresearch.com/request-for-customization/203
Allogenic stem cells segment to account for largest revenue share in the global market over the forecast period owing to increasing application of allogenic stem cells in various cell-based therapies and rising availability of stem cell therapy products based on allogenic stem cells.
Musculoskeletal diseases segment is expected to register significant revenue growth over the forecast period owing to increasing prevalence of musculoskeletal disorders and increasing application of regenerative medicine to treat bone and joint diseases.
Research application segment is expected to register robust revenue CAGR over the forecast period owing to increasing investment and funding to advance stem cell research and accelerate development of cell-based therapeutic products.
North America is expected to account for largest revenue share between 2021 and 2028 owing to rising private and public funding, increasing number of research activities, financial support from government to accelerate stem cell research, increasing incidence of musculoskeletal and bone and joint disorders, and presence of key players in the region.
In September 2021, BioRestorative Therapies, Inc. announced that it had received a patent for its metabolic ThermoStem Program from the Australian Patient Office
Highlights of the Adipose-derived Stem Cell Market Report:
This research report focuses on the Adipose-derived Stem Cell Market overview, market share, demand and supply ratio, and import/export details, supply chain analysis, and others.
The report includes different approaches and procedures used by established market players for efficient business decisions.
The report offers detailed information regarding the production value, strategies adopted by the key market players, their products/services offerings, and many more.
Read More: https://www.emergenresearch.com/industry-report/adipose-derived-stem-cell-market
Related Reports:
Desktop 3D Printer Market:https://www.emergenresearch.com/industry-report/desktop-3d-printer-market
LED Emergency Lighting Market: https://www.emergenresearch.com/industry-report/led-emergency-lighting-market
Human Centric Lighting Market: https://www.emergenresearch.com/industry-report/human-centric-lighting-market
Beacon Technology Market: https://www.emergenresearch.com/industry-report/beacon-technology-market
Solar LED Street Lighting Market: https://www.emergenresearch.com/industry-report/solar-led-street-lighting-market
About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Facebook | LinkdIn | Twitter | Blogs